| Intensive chemotherapeutic regimens against acute leukemia transiently suppress asthma symptoms but do not lead to long-term relief. | |
| | |
MedLine Citation:
|
PMID: 11127397 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In some very rare cases children suffer from a combination of asthma and a malignant disease. This study investigated whether intensive chemotherapy might have a positive effect on asthma in these special cases and whether asthma generally relapses after completion of chemotherapy. The authors monitored clinical outcome and lung function of 43 children with acute lymphoblastic leukemia and non-Hodgkin lymphoma who received chemotherapy at the University Children's Hospital of Greifswald between 1993 and 1998. Cytostatic chemotherapy was administered according to the German treatment protocols. Two of the 43 patients had asthma before leukemia was diagnosed. During the course of chemotherapy, asthma symptoms diminished promptly after beginning of chemotherapy but asthma was rediagnosed after completion of chemotherapy in both cases. The third patient developed asthmatic symptoms shortly after completion of chemotherapy for the first time. It can be stated that chemotherapy does not essentially cure asthma. Therefore, it seems mandatory to perform follow-up lung testings after chemotherapy, especially in patients with asthma. |
| | |
Authors:
|
S Weigel; S M Schmidt; T Bernig; S Mukodzi; J F Beck; E H Ballke; S K Wiersbitzky |
Related Documents
:
|
23331717 - Altering the therapeutic paradigm towards a distal bowel margin of less than 1 cm in pa... 22987147 - Evaluation of a prospective surgical strategy of extended resection to achieve r0 statu... 23132417 - Impact of age and co-morbidity on surgical resection rate and survival in patients with... 23580117 - Ct-guided radioactive (125)i seed implantation therapy of symptomatic retroperitoneal l... 3343027 - Follicular non-hodgkin's lymphoma in hong kong chinese: a retrospective analysis. 22837187 - Sunitinib in refractory adrenocortical carcinoma: a phase ii, single-arm, open-label tr... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Pediatric hematology and oncology Volume: 17 ISSN: 0888-0018 ISO Abbreviation: Pediatr Hematol Oncol Publication Date: 2000 Dec |
Date Detail:
|
Created Date: 2000-12-13 Completed Date: 2001-02-22 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8700164 Medline TA: Pediatr Hematol Oncol Country: England |
Other Details:
|
Languages: eng Pagination: 659-65 Citation Subset: IM |
Affiliation:
|
University Children's Hospital, Ernst-Moritz-Arndt-University Greifswald, Greifswald, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents
/
therapeutic use* Asthma / complications*, drug therapy Child Child, Preschool Humans Immunosuppression* Lymphoma, Non-Hodgkin / complications*, drug therapy Male Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*, drug therapy Recurrence Respiratory Function Tests Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents |
| Comments/Corrections | |
Comment In:
|
Pediatr Hematol Oncol. 2001 Sep;18(6):421-2
[PMID:
11554239
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
Next Document: Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotyp...